NCT00942422 · MORE INFO

Limitations, agreements, and source contact

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma · Source last updated 2015-03-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: true
restrictive Agreement: false

limitations And Caveats

description: Low accrual and early termination limits the conclusions one could draw. Although no pts on this trial met the primary endpoint of a 25% or greater M-protein reduction, the small number of pts enrolled prohibits formal statistical analysis.

point Of Contact

email: zonderj@karmanos.org
organization: Barbara Ann Karmanos Cancer Institute
phone: 313-576-8732
title: Jeffrey Zonder, M.D.

Complete source fields

certain Agreement

pi Sponsor Employee: true
restrictive Agreement: false

limitations And Caveats

description: Low accrual and early termination limits the conclusions one could draw. Although no pts on this trial met the primary endpoint of a 25% or greater M-protein reduction, the small number of pts enrolled prohibits formal statistical analysis.

point Of Contact

email: zonderj@karmanos.org
organization: Barbara Ann Karmanos Cancer Institute
phone: 313-576-8732
title: Jeffrey Zonder, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice